Community Acquired Pneumonia Research Report 2025: Market Expected to Reach USD 3.09 Billion by 2032 - Explore the Impact of Combination Therapies and Diagnostic Advances [Yahoo! Finance]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Yahoo! Finance
The global market for community-acquired pneumonia treatments is experiencing significant growth, largely driven by an increasing incidence of the condition. Demographics such as the elderly and those with compromised immune systems are particularly at risk, and the market shows a rising demand for more effective treatments. Technological advancements in diagnostics and therapeutics are also catalyzing growth. A notable CAGR of 7.7% is projected between 2024-2032, with an expected market valuation of USD 3.09 billion by 2032. Challenges and Opportunities The community-acquired pneumonia market faces challenges such as the surge in antibiotic-resistant bacteria and the high costs associated with advanced treatments. Delayed diagnosis and limited awareness in certain regions complicate disease management and treatment accessibility. However, the market opportunities thrive with the innovation in antibiotic development and the expansion of vaccination programs. There are also opport
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Down 80%, Should You Buy the Dip on Moderna? [Yahoo! Finance]Yahoo! Finance
- Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with AnalystsBusiness Wire
- If I Could Only Buy and Hold a Single Stock, This Would Be It [Yahoo! Finance]Yahoo! Finance
- Pfizer Adds to Its Big Bet on Weight Loss Drugs [Yahoo! Finance]Yahoo! Finance
- Pfizer: Ignoring The Dead Cat Bounce [Seeking Alpha]Seeking Alpha
PFE
Earnings
- 11/4/25 - Beat
PFE
Sec Filings
- 12/17/25 - Form 4
- 12/16/25 - Form 8-K
- 12/2/25 - Form 4
- PFE's page on the SEC website